首页> 外文期刊>Molecular biology reports >Chemokine gene polymorphisms association with increased risk of type 2 diabetes mellitus in Tatar ethnic group, Russia
【24h】

Chemokine gene polymorphisms association with increased risk of type 2 diabetes mellitus in Tatar ethnic group, Russia

机译:趋化因子基因多态性与俄罗斯塔塔尔族群2型糖尿病风险增加

获取原文
获取原文并翻译 | 示例
           

摘要

Recent studies have shown that chemokines play an important role in the development of chronic inflammation in adipose tissue, obesity pathogenesis, glucose intolerance and type 2 diabetes. It has also been revealed that some SNPs in chemokine genes are associated with obesity, insulin resistance, type 2 diabetes and diabetes complications in different ethnic groups. The aim of this study was to determine the associations between SNPs in chemokine genes and type 2 diabetes in participants of Tatar ethnic group, living in Bashkortostan. Case-control and cross-sectional study were included in our study design. Five SNPs were genotyped in 440 type 2 diabetes (160 men and 280 women), 58.8 +/- 9.2 years old (mean +/- SD), BMI 29.3 +/- 3.9 kg/m(2) (mean +/- SD) patients of Tatar ethnicity, and a control group of 500 Tatars (180 men and 320 women), 55.2 +/- 11.6years old (mean +/- SD), BMI 25.9 +/- 4.3 kg/m(2) (mean +/- SD). The SNPs rs6749704 in CCL20 [odds ratio (OR)=2.77 (95% CI 1.81-4.25), p=0.0001], rs2107538 in CCL5 [odds ratio (OR)=1.80 (95% CI 1.46-2.22), p=0.0001] were significantly associated with type 2 diabetes. Regression analysis revealed that rs1696941 in CCL11 was associated with the onset age and duration of type 2 diabetes as well as with HbA(1c) level (p=0.034, p=0.036 and p=0.0054, respectively). The SNPs rs223828 in CCL17 and rs6749704 in CCL20 were correlated with obesity as estimated by BMI (p=0.0004, p=0.029, respectively). Rs223828 in CCL17 revealed the association with postprandial glucose level (p=0.024) and HbA(1c) (p=0.008). These data demonstrate that variants of chemokine genes are associated with type 2 diabetes and obesity of Tatar ethnic group inhabiting Bashkortostan Republic. Novel associations of the polymorphic loci in CCL20 (rs6749704) and CCL5 (rs2107538) genes with type 2 diabetes had been identified as a result of the conducted research.
机译:最近的研究表明,趋化因子在脂肪组织,肥胖发病机制,葡萄糖不耐受和2型糖尿病中发挥慢性炎症的发展。还揭示了趋化因子基因中的一些SNP与肥胖,胰岛素抵抗,2型糖尿病和糖尿病在不同族群中的并发症有关。本研究的目的是确定趋化因子基因中SNP和塔塔尔族群参与者中的2型糖尿病之间的关联,居住在Bashkortostan。我们的研究设计中包含案例控制和横截面研究。 440型糖尿病(160名男性和280名女性),58.8 +/- 9.2岁(平均+/- SD),BMI 29.3 +/- 3.9千克/米(平均+/- SD) )鞑靼人患者,500名鞑靼人(180名男性和320名女性),55.2 +/- 11.6年(平均+/- SD),BMI 25.9 +/- 4.3千克/ m(2)(平均值+/- SD)。 CCL20中的SNPS RS6749704 [差距(或)= 2.77(95%CI 1.81-4.25),p = 0.0001],CCL5中的RS2107538 [差距(或)= 1.80(95%CI 1.46-222),P = 0.0001 ]与2型糖尿病有显着相关。回归分析显示,CCL11中的RS1696941与2型糖尿病的发作年龄和持续时间以及HBA(1C)水平有关(P = 0.034,P = 0.036和P = 0.0054)。 CCL17中的SNPS RS223828和CCL20中的RS6749704与BMI估计的肥胖有关(分别为P = 0.0004,P = 0.029)相关。 CCL17中的RS223828揭示了与餐后葡萄糖水平(P = 0.024)和HBA(1C)的关联(P = 0.008)。这些数据表明,趋化因子基因的变体与居住在巴什科斯坦共和国的塔塔尔族裔族裔型糖尿病和肥胖有关。由于进行的研究,已鉴定CCL20(RS6749704)和CCL5(RS2107538)和CCL5(RS2107538)基因的新型缔合品。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号